Teva Pharmaceutical Industries (TEVA) climbed above an important chart level Wednesday, after the company's bullish guidance overshadowed mixed second-quarter results. And Biogen (BIIB) rallied after it beat Q2 estimates. Teva earnings thinned to 2 cents a share after subtracting costs from an acquisition. The profit came in below the consensus estimate of 5 cents a share. Revenue fell 1% to…
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views
Kaynak: Yahoo Finance
İlgili Haberler
Global
Divided Fed holds interest rates steady, but three members voted to hike
CNBC Finance · 1 saat önce
Global
Analyst Report: HF Sinclair Corp
Yahoo Finance · 1 saat önce
Global
Here's what changed in the second Fed statement under Warsh
CNBC Finance · 2 saat önce
Global
Types of life insurance: A complete guide
Yahoo Finance · 2 saat önce
Global
Coke is thriving on same consumer behavior Pepsi says is fading
Yahoo Finance · 2 saat önce
Yorumlar (0)
Giriş yaparak yorum yazabilirsin.
İlk yorumu sen yaz.